Dergiler / Psychiatry and behavioral sciences (Online) / 2018 / Cilt: 8 - Sayı: 4

Parkinsonism Due to the Use of Long-Term High-Dose Valproic Acid in an Elderly Patient with Mania Syndrome: A Case Report and Literature Review

Sayfa
199–203
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Based on this case, it can be put forward that addressing psychiatry patients who have a long-term use of VPA in terms of parkinsonism symptoms can be significant in terms of not overlooking this side effect that can disrupt the quality of life and also in terms of early diagnosis and treatment.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Valproic acid (VPA) is used as a mood stabilizer in the treatment of bipolar disorder and is commonly associated with central nervous system side effects.
📊
Temel Bulgular & Veri:Furthermore, the relationship between VPA treatment dose and parkinsonism symptom severity is uncertain. 72-year-old male patient has been followed-up for 30 years with a diagnosis of bipolar disorder and has been receiving a treatment of VPA.
💡
Sonuç & Katkı:Based on this case, it can be put forward that addressing psychiatry patients who have a long-term use of VPA in terms of parkinsonism symptoms can be significant in terms of not overlooking this side effect that can disrupt the quality of life and also in terms of early diagnosis and treatment.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Valproic acid (VPA) is used as a mood stabilizer in the treatment of bipolar disorder and is commonly associated with central nervous system side effects. The most common side effect is tremor due to dose, while parkinsonism is a less common side effect. Among psychiatric patients, there are few reports of recurrent parkinsonism attributed to VPA use. However, in the literature, especially among neurological patients, VPA is one of the main important causes of Parkinsonism. Furthermore, the relationship between VPA treatment dose and parkinsonism symptom severity is uncertain. 72-year-old male patient has been followed-up for 30 years with a diagnosis of bipolar disorder and has been receiving a treatment of VPA. After VPA treatment was started, complaints of impairment in speech, walking with small steps, slowed movements, and imbalance which had gradually increased, started within the last 10 years. The patient was admitted to the clinic and assessed for secondary parkinsonism. VPA treatment of the patient was stopped since he was thought to have secondary parkinsonism associated with medication. 4 days after the VPA medication was stopped, it was seen that there was a decrease in bending forward posture and regression in dysphagia and the patient was seen to walk alone without any support. Based on this case, it can be put forward that addressing psychiatry patients who have a long-term use of VPA in terms of parkinsonism symptoms can be significant in terms of not overlooking this side effect that can disrupt the quality of life and also in terms of early diagnosis and treatment.

🔖

Bu Makaleye Atıf Yap

AYKUT, D. S., ARAL, G., TİRYAKİ, A. (2018). Parkinsonism Due to the Use of Long-Term High-Dose Valproic Acid in an Elderly Patient with Mania Syndrome: A Case Report and Literature Review. Psychiatry and behavioral sciences (Online), Cilt: 8 - Sayı: 4, 199–203. https://ajindex.com/articles/302847

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (16)

  1. Bergman H, Deuschl G. Pathophysiology of Parkinson's disease: from clinical neurology to basic neuroscience and back. Mov Disord 2002;17(Suppl 3):S28-40
  2. Friedman JH. Drug-Induced parkinsonism. In: Lang AE, Weiner WJ, eds. Drug-Induced Movement Disorders. 1st ed. Mount Kisco, NY: Futura; 1992:41-83
  3. Shin HW, Chung SJ. Drug-induced parkinsonism. J Clin Neurol 2012;8(1):15-21
  4. Athauda D, Batley R, Ellis C. Clinically silent idiopathic Parkinson’s disease unmasked by valproate use: a brief report. Aging Clin Exp Res 2015;27(3):387–90
  5. Johannessen CU. Mechanisms of action of valproate: a commentatory. Neurochem Int 2000;37(2-3):103-10
  6. Easterford K, Clough P, Kellett M, Fallon K, Duncan S. Reversible parkinsonism with normal beta-CIT-SPECT in patients exposed to sodium valproate. Neurology 2004;62(8):1435–7
  7. Brugger F, Bhatia KP, Besag FM. Valproate-associated parkinsonism: a critical review of the literature. CNS Drugs 2016;30(6):527-40
  8. Hassamal S, Waller S, Reese K, Testa C. Reversible valproic acid-induced parkinsonism and cognitive impairment in an elderly patient with Bipolar Disorder I. Turk Psikiyatri Derg 2016;27(3)-213-7. (Turkish
  9. Silver M, Factor SA. Valproic acid-induced parkinsonism: levodopa responsiveness with dyskinesia. Parkinsonism Relat Disord 2013;19(8):758-60
  10. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978;133:429-35
  11. Karadag F, Oral ET, Yalcin FA, Erten E. Reliability and validity of Turkish translation of Young Mania Rating Scale. Turk Psikiyatri Derg 2002;13(2):107-14. (Turkish
  12. Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatri Res 1975;12(3):189-98
  13. Gungen C, Ertan T, Eker E, Yasar R, Engin F. Reliability and validity of the standardized mini mental state examination in the diagnosis of mild dementia in Turkish population. Turk Psikiyatri Derg 2002;13(4):273-81. (Turkish
  14. Akbostanci MC, Balaban H, Atbasoglu C. Interrater reliability study of motor examination subscale of UPDRS and AIMS. Parkinson Hastalığı Hareket Bozuklukları Dergisi 2000;3:7-13
  15. Kose S, Akin E, Cetin M. Adverse drug reactions and causality: the Turkish version of Naranjo Adverse Drug Reactions Probability Scale, Psychiatry and Clinical Psychopharmacology 2017;27(2):205-6
  16. Lautin A, Stanley M, Angrist B, Gershon S. Extrapyramidal sy